<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83625">
  <stage>Registered</stage>
  <submitdate>17/02/2009</submitdate>
  <approvaldate>5/01/2012</approvaldate>
  <actrnumber>ACTRN12612000018819</actrnumber>
  <trial_identification>
    <studytitle>New imaging technologies in the detection of colitis related colon cancer</studytitle>
    <scientifictitle>A prospective study assessing the outcomes of chromoendoscopy and narrow band imaging in colitis surveillance for dysplasia</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Not applicable</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Dysplasia in Colitis</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Inflammatory bowel disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Bowel - Back passage (rectum) or large bowel (colon)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients undergo standard colonoscopy until the caecum is reached.  Only a single colonoscopy will be performed on each patient (one-off).

Once the caecum is reached, all patients undergo sequential examination of colonic segments (as defined by the hepatic and splenic flexures) initially by NBI and then by chromoendoscopy. 

The NBI and chromoendoscopy examinations are undertaken by two independent endoscopists.

NBI is activated by selecting a button on the standard colonoscope.  It is then deactivated at the end of the examination of that segment. 

There are no time limits imposed on the examination times however typically each examination takes 2-3minutes to examine.</interventions>
    <comparator>Once a segment is examined by NBI then an independent endoscopist blinded to the results of the NBI examination examines the same segment using choromoendoscopy.

Chromoendoscopy involves applying 0.1% methylene blue solution to the bowel lining using a spray catheter and then examining that area. 

There are no time limits imposed on the examination times however typically each examination takes 2-3minutes to examine.</comparator>
    <control>Active</control>
    <interventioncode>Early detection / Screening</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Diagnostic yield for dysplasia</outcome>
      <timepoint>At conclusion of the colonoscopy, the diagnostic yield for dysplasia will be measured for NBI and chromoendoscopy.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Accuracy of the Kudo classification by NBI in predicting neoplasia, calculated by comparing the prediction of neoplastic versus non neoplastic classification by NBY to actual histology.</outcome>
      <timepoint>At the conclusion of the study, the accuracy of the Kudo classification by NBI of any identified lesions will be calculated.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age 18 and above
Long standing colitis (8 years or more)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Nil</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/03/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>St Vincents Hospital</primarysponsorname>
    <primarysponsoraddress>41 Victoria Parade, Fitzroy, VIC 3065</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>St Vincents Hospital</fundingname>
      <fundingaddress>41 Victoria Parade, Fitzroy, VIC 3065</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A study comparing NBI and chromoendoscopy for dysplasia surveillance in patients with chronic colitis.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St Vincent's Hospital HREC A</ethicname>
      <ethicaddress>41 Victoria PArade, Fitzroy VIC 3065</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>17/02/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Marios Efthymiou</name>
      <address>St Vincents Hospital
41 Victoria Parade, Fitzroy, VIC 3065</address>
      <phone>+613 92884410</phone>
      <fax>+613 86781032</fax>
      <email>mariosefthymiou@hotmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Marios Efthymiou</name>
      <address>St Vincents Hospital
41 Victoria Parade, Fitzroy, VIC 3065</address>
      <phone>+613 92884410</phone>
      <fax>+613 86781032</fax>
      <email>mariosefthymiou@hotmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>